JPH0788201A - Therapeutic device composition - Google Patents
Therapeutic device compositionInfo
- Publication number
- JPH0788201A JPH0788201A JP5187562A JP18756293A JPH0788201A JP H0788201 A JPH0788201 A JP H0788201A JP 5187562 A JP5187562 A JP 5187562A JP 18756293 A JP18756293 A JP 18756293A JP H0788201 A JPH0788201 A JP H0788201A
- Authority
- JP
- Japan
- Prior art keywords
- foot
- parts
- weight
- composition
- athlete
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Radiation-Therapy Devices (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
(57)【要約】
【目的】 肩,手,足などの凝りや足腰の疲労感の回復
から水虫の抑制や発生を防ぐ治療器体の組成物にある。
【構成】 遠赤外線の発生源となるセラミック粉体と、
防カビ剤と、残部を結合媒体となる有機高分子材料とで
組成物1〜3を構成する。
(57) [Summary] [Purpose] The present invention provides a composition for a therapeutic device that prevents or prevents the occurrence of athlete's foot from the recovery of stiffness in the shoulders, hands, feet, etc. and fatigue in the legs and waist. [Structure] Ceramic powder as a source of far infrared rays,
Compositions 1 to 3 are composed of an antifungal agent and the rest an organic polymer material serving as a binding medium.
Description
【0001】[0001]
【産業上の利用分野】本発明は、治療器体の組成物に係
り、詳しくは肩,手,足などの凝りや腰痛から足腰の疲
労感の回復、さらに水虫の抑制などの治癒促進に有効に
作用する治療器体の組成物に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a therapeutic device composition, and more specifically, it is effective for recovery of tiredness in the legs and waist from stiffness in the shoulders, hands, feet and the like, back pain, and promotion of healing such as suppression of athlete's foot. The present invention relates to a composition of a therapeutic device that acts on the.
【0002】[0002]
【従来の技術】従来、磁気を用いた磁気治療器は、肩凝
りや腰痛、骨折後の治癒の促進などに治療効果があり、
種々な構成のものが開発され、市販されている。2. Description of the Related Art Conventionally, a magnetic therapy device using magnetism has a therapeutic effect on shoulder stiffness, low back pain, promotion of healing after fracture, etc.
Various configurations have been developed and are commercially available.
【0003】一般的に、この種従来の磁気治療器は、人
体の所望患部に装着させるため、磁気を帯びた永久磁石
の磁気体を粘着性シートに付設させる構成になってい
る。そして、この磁気治療器は、肩凝りなどの患部に粘
着シートを介して装着させると、その磁石から発生する
磁力線が体内に浸透し、治療効果を発揮すると理解され
ている。In general, a conventional magnetic therapy device of this kind is constructed such that a magnetic permanent magnet is attached to an adhesive sheet in order to be attached to a desired affected part of a human body. It is understood that when this magnetic therapeutic device is attached to an affected area such as a stiff shoulder via an adhesive sheet, magnetic lines of force generated from the magnet penetrate into the body to exert a therapeutic effect.
【0004】[0004]
【発明が解決しようとする課題】しかしながら、従来の
磁気治療器は、このような永久磁石の磁気体を単体で使
用しているため、磁気体のみの治療効果しか認められ
ず、それ以上の治療効果は期待できないものである。However, since the conventional magnetic therapy device uses such a magnetic body of a permanent magnet alone, only the therapeutic effect of the magnetic body is recognized, and further treatment is not possible. The effect cannot be expected.
【0005】ところで、ジルコニア,チタニア,アルミ
ナ,コージライト(2MgO ・2Al2O3・5SiO2 )、βスポ
ジウメン(Li2O・Al2O3 ・TiO2) 、チタン酸アルミニウ
ム(AL2O3・TiO2)などの所謂、セラミック材料は、遠赤
外線を放出し、その強度は絶対温度の4乗に比例するこ
とが知られている。この遠赤外線は、生体に効率的に吸
収されるため、例えばセラミック材料から放射される遠
赤外線を暖房器具に使用することにより、対流による暖
房を輻射熱暖房に変換して、その効率を高める技術が確
立している。Meanwhile, zirconia, titania, alumina, cordierite (2MgO · 2Al 2 O 3 · 5SiO 2), β Supojiumen (Li 2 O · Al 2 O 3 · TiO 2), aluminum titanate (AL 2 O 3 · It is known that so-called ceramic materials such as TiO 2 ) emit far infrared rays and the intensity thereof is proportional to the fourth power of the absolute temperature. Since this far infrared ray is efficiently absorbed by the living body, for example, by using far infrared ray emitted from a ceramic material for a heating appliance, there is a technique for converting convection heating into radiant heating to increase its efficiency. Has been established.
【0006】また、この遠赤外線は、これを人体に適用
して、肩や手足の凝りを治療することが試みられてお
り、本願出願人は、先に磁気と遠赤外線を一体化した治
療器体について平成5年実用新案登録願第22478号
を提出している。Further, it has been attempted to apply the far infrared rays to a human body to treat stiffness of the shoulders and limbs, and the applicant of the present application has previously proposed a therapeutic device that combines magnetism and far infrared rays. Regarding the body, 1993 utility model registration application No. 22478 has been submitted.
【0007】この治療器体は、肩,手,足などの凝りの
治癒の他に、靴下の中に入れて足の裏側などに密着させ
ることにより、疲労回復に顕著な効果を発揮すると共
に、水虫の発生をも抑制することが認められた。この効
果は、上記実用新案登録願の治療器体における支持体と
してのエラストマーにブレンドしたセラミック粉体のみ
でも発揮され、必ずしも磁気の作用は必要ではないこと
も明らかになった。In addition to healing stiffness of the shoulders, hands, feet, etc., this therapeutic device exerts a remarkable effect on fatigue recovery by putting it in socks and closely contacting it with the soles of the feet. It was also found to suppress the development of athlete's foot. It was also clarified that this effect is exhibited only by the ceramic powder blended with the elastomer as the support in the therapeutic device body of the above-mentioned utility model registration application, and the magnetic action is not always necessary.
【0008】わが国は温暖多湿の気候風土あり、カビの
生育に適している。梅雨の季節には、この傾向が特に著
しい。カビはみそ,醤油,酒類などの醗酵食品の製造、
アルコール工業、抗生物質、ビタミン、酵素などの医薬
品工業の発展に寄与する一方で、人間生活に数多くの危
害をもたらしている。例えば、各種食品について変質、
腐敗を引き起こし、農作物に被害をもたらし、さらに水
虫などの皮膚病の原因となったり、アルミニウム,プラ
スチック材料などの工業材料を変質或いは腐食させてい
る。プラスチック,ゴムなどの有機高分子材料にあって
は、蛋白質類を含む天然ゴムをはじめ、乳化剤を含むA
BS樹脂、さらにポリエチレン,ポリプロピレンなどの
ポリオレフィン類にまで、その被害は及んでいる。Japan has a warm and humid climate and is suitable for mold growth. This tendency is particularly remarkable in the rainy season. Mold production of fermented foods such as miso, soy sauce, alcoholic beverages,
While contributing to the development of the pharmaceutical industry such as the alcohol industry, antibiotics, vitamins and enzymes, it has caused many harms to human life. For example, alteration of various foods,
It causes putrefaction, damages agricultural products, causes skin diseases such as athlete's foot, and alters or corrodes industrial materials such as aluminum and plastic materials. For organic polymer materials such as plastics and rubber, natural rubber containing proteins as well as A containing emulsifier
The damage extends to BS resins and even polyolefins such as polyethylene and polypropylene.
【0009】このような有機高分子類に発生するカビを
抑制するには、一般に防カビ剤を添加し、練り込んでい
る。防カビ剤には、次のようなものが知られている(繊
維学会編の「繊維便覧」による)。 1 フェノール系化合物 ペンタクロルフェノール(PCP)、サリシルアニリド(Shi
rlan) 、2.2'- ジヒドロキシ-3.5,6.3'.5'.6'-ヘキサク
ロロ- ジフェニルメタン(G-11)、2.2'- ジヒドロキシ-
5.5'-ジクロロ- ジフェニルメタン(G-4) 、テトラブロ
モ-0- クレゾールなど。 2 有機銅化合物 ナフテン酸銅、Cu-8- キノリノレート、Cu- ジエチルジ
チオカルバメート、ペンタクロロフェノール銅塩など。 3 有機亜鉛化合物 2n- ジメチル( またはエチル) ジチオカルバメート、ナ
フテン酸亜鉛など。 4 有機錫化合物 トリエチル-n- オクチル錫、ジエチルフッニル錫アセテ
ート、トリメチル錫アセテート、トリエチル錫クロリ
ド、ブロピル錫トリオリエート、トリブチル錫オキシド
など。 5 有機水銀化合物 フェニルマーキュリックアセテート、フェニルマーキュ
リック・ジオクチル・スルホサクシネート、フェニルマ
ーキュリック・ジナフチルメタン・ジスルホネート、ピ
リジニルマーキュリックアセテートなど。 6 第4級アンモニウム塩化合物 ジメチル・ベンジル・アルキル( 例: ステアリル) ・ア
ンモニウムクロリド、ジイソブチルクレゾキシ( または
フェノキシ) ・エトキシエチル・ジメチル・ベンジル・
アンモニウムクロリド、セチルトリメチルアンモニウム
プロミド、セチルピリジニウムクロリド、アルキルベン
ゾイルインドゾールなど。しかし、皮膚への刺激などの
問題から、上記1及び2はあまり好ましいものではな
い。In order to suppress the mold generated in such organic polymers, generally, an antimold agent is added and kneaded. The following are known as antifungal agents (according to "Textile Handbook" edited by The Textile Society of Japan). 1 Phenolic compounds Pentachlorophenol (PCP), Salicylanilide (Shi
rlan), 2.2'-dihydroxy-3.5,6.3'.5'.6'-hexachloro-diphenylmethane (G-11), 2.2'-dihydroxy-
5.5'-dichloro-diphenylmethane (G-4), tetrabromo-0-cresol, etc. 2 Organic copper compounds Copper naphthenate, Cu-8-quinolinolate, Cu-diethyldithiocarbamate, pentachlorophenol copper salt, etc. 3 Organozinc compounds 2n- dimethyl (or ethyl) dithiocarbamate, zinc naphthenate, etc. 4 Organotin compounds Triethyl-n-octyl tin, diethyl phenyl tin acetate, trimethyl tin acetate, triethyl tin chloride, propyl tin trioleate, tributyl tin oxide and the like. 5 Organic mercury compounds such as phenyl mercuric acetate, phenyl mercuric dioctyl sulfosuccinate, phenyl mercuric dinaphthyl methane disulfonate, and pyridinyl mercuric acetate. 6 Quaternary ammonium salt compounds Dimethyl benzyl alkyl (eg stearyl) -Ammonium chloride, diisobutyl cresoxy (or phenoxy) -Ethoxyethyl dimethyl benzyl
Ammonium chloride, cetyl trimethyl ammonium bromide, cetyl pyridinium chloride, alkyl benzoyl indozole, etc. However, due to problems such as skin irritation, the above 1 and 2 are not very preferable.
【0010】本願発明者らは、このような遠赤外線の有
効利用を種々研究開発を重ねた結果、セラミック粉、防
カビ剤及び有機高分子材料からなる治療器体の組成物を
開発したものである。The inventors of the present application have conducted various researches and developments on the effective use of such far infrared rays, and as a result, have developed a composition for a therapeutic device comprising a ceramic powder, a fungicide and an organic polymer material. is there.
【0011】本発明は、このような事情に鑑みてなされ
たものであり、その目的とするところは、肩凝りや疲労
感の回復、水虫の抑制など人体の治療に有効に作用する
治療器体の組成物を提供するものである。The present invention has been made in view of the above circumstances, and an object thereof is to provide a therapeutic device which effectively acts on the treatment of the human body such as recovery from stiff shoulders, fatigue and suppression of athlete's foot. The present invention provides a composition of
【0012】[0012]
【課題を解決するための手段】本発明に係る治療器体の
組成物は、このような目的を達成するために、直径2〜
500μの遠赤外線の発生源となるセラミック粉体10
〜90重量部と、防カビ剤0.5 〜10.0重量部と、残部を
結合媒体となる有機高分子材料とすることを特徴とする
ものである。In order to achieve such an object, the composition of the therapeutic device according to the present invention has a diameter of 2 to
Ceramic powder 10 as a source of far infrared rays of 500μ
.About.90 parts by weight, 0.5 to 10.0 parts by weight of the fungicide, and the balance of the organic polymer material as a binding medium.
【0013】さらに、本発明は、内部に表面磁束密度2
00〜20000ガウスの磁石をインサートして一体成
形したことを特徴とするものである。Furthermore, the present invention has a surface magnetic flux density of 2
It is characterized by being integrally molded by inserting a magnet of 00 to 20000 Gauss.
【0014】[0014]
【作用】本発明にあっては、組成物を人体の患部に直接
当てがうことにより、その磁力線と遠赤外線との相乗効
果により患部の治療或いは痛みなどの軽減が図れる。ま
た、防カビ剤の働きで、水虫の発生及び抑制が図れる。In the present invention, by directly applying the composition to the affected part of the human body, the synergistic effect of the magnetic lines of force and the far infrared rays can treat the affected part or reduce pain. Further, the action of the fungicide can promote the generation and control of athlete's foot.
【0015】[0015]
【実施例】以下、本発明の実施例を図面を参照しながら
説明すると、図1は本発明の第1例を示す斜視図、図2
及び図3は第2,第3の例を示す斜視図、図4は本発明
の第4例の断面図である。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS An embodiment of the present invention will be described below with reference to the drawings. FIG. 1 is a perspective view showing a first embodiment of the present invention, and FIG.
3 and 4 are perspective views showing second and third examples, and FIG. 4 is a sectional view of a fourth example of the present invention.
【0016】図1に示す組成物1は、円盤状に成形した
組成物であり、図2に示す組成物2は、角状に成形した
組成物を表している。これら組成物1,2は、セラミッ
ク粉体、防カビ剤及び有機高分子材料よりなり、直径2
〜500μの遠赤外線の発生源となるセラミック粉体1
0〜90重量部と、防カビ剤0.5 〜10.0重量部と、残部
を有機高分子材料とからなり、円盤状や角状など所定の
形状に成形されている。The composition 1 shown in FIG. 1 is a disc-shaped composition, and the composition 2 shown in FIG. 2 is a square-shaped composition. These compositions 1 and 2 are composed of a ceramic powder, a fungicide and an organic polymer material and have a diameter of 2
Ceramic powder 1 as a source of far infrared rays of ~ 500μ
It is composed of 0 to 90 parts by weight, 0.5 to 10.0 parts by weight of antifungal agent, and the balance of the organic polymer material, and is formed into a predetermined shape such as a disc shape or a square shape.
【0017】セラミック粉体は、遠赤外線の発生源とな
り得るものであればよく、ジルコニア,チタニア,アル
ミナ,コージライト(2MgO ・2Al2O3・5SiO2 )、βス
ポジウメン(Li2O・Al2O3 ・TiO2) 、チタン酸アルミニ
ウム(AL2O3・TiO2)など遠赤外線を有するセラミック材
料はすべて使用できる。その粒度は、直径2〜500μ
が好適であり、粒度があまり小さいと、取り扱い時に超
微粒が粉塵となってしまう。また、大きな粒度である
と、結合媒体である有機高分子材料との均質な成形が難
しくなるため、上記の範囲の粒度が好ましい。The ceramic powder may be any one which can be a far-infrared sources, zirconia, titania, alumina, cordierite (2MgO · 2Al 2 O 3 · 5SiO 2), β Supojiumen (Li 2 O · Al 2 O 3 · TiO 2), a ceramic material having a far-infrared aluminum titanate (AL 2 O 3 · TiO 2 ) are all available. The particle size is 2-500μ in diameter
Is preferable, and if the particle size is too small, the ultrafine particles become dust during handling. Further, when the particle size is large, it becomes difficult to form a homogeneous molding with the organic polymer material which is the binding medium, so the particle size in the above range is preferable.
【0018】セラミック粉体の添加量は、多い程その治
療効果の面で好ましいが、組成物100重量部中、10
〜90重量部、好ましくは20〜80重量部が好適であ
る。添加量がこれよりも少ないと、治療効果が乏しくな
り、多いと成形が困難となる。可能な限り多量のセラミ
ック粉体をブレンドするためには、後記するように有機
高分子材料としてポリ塩化ビニル樹脂と可塑剤とからな
るペーストを使用することが好ましい。The larger the amount of the ceramic powder added, the more preferable it is from the viewpoint of its therapeutic effect.
˜90 parts by weight, preferably 20-80 parts by weight is suitable. If the added amount is less than this, the therapeutic effect becomes poor, and if the added amount is too large, molding becomes difficult. In order to blend as much ceramic powder as possible, it is preferable to use a paste composed of a polyvinyl chloride resin and a plasticizer as the organic polymer material, as will be described later.
【0019】次に、結合媒体となる有機高分子材料とし
ては、殆ど全ての有機高分子材料を使用できる。ポリエ
チレン、ポリプロピレン、硬質ポリ塩化ビニルなど一般
に広く用いられている汎用合成樹脂類は勿論のこと、天
然ゴム、SBR、NBR、CRなどの合成ゴム類、及び
PS−ポリブタジエン−PS型ブロックポリマー、オレ
フィン樹脂を拘束相とするTRE(熱可塑性エラストマ
ー)、ポリ塩化ビニル系TPE(特に高重合度塩ビを用
いた軟質コンパウンド)、ウレタン系TPE、エステル
系TPE、アミド系TPE、1,2−ポリブタジエン、
トランス・ポリイソプレンなどの所謂、熱可塑性エラス
トマー類が使用可能で、特に熱可塑性エラストマーは、
防カビ類の効果発現性、射出成形性、及び人体に装着し
た際の風合いにおいて優れている。本願発明者らの研究
によれば、この熱可塑性エラストマーとして、株式会社
クラレのハイプラーを用いることにより、優れた組成物
の試作に成功した。Next, almost all organic polymer materials can be used as the organic polymer material serving as the binding medium. Not only general-purpose synthetic resins that are generally widely used such as polyethylene, polypropylene, and rigid polyvinyl chloride, but also natural rubber, synthetic rubbers such as SBR, NBR, and CR, PS-polybutadiene-PS type block polymer, and olefin resin TRE (thermoplastic elastomer) containing as a constraining phase, polyvinyl chloride type TPE (particularly a soft compound using high polymerization degree vinyl chloride), urethane type TPE, ester type TPE, amide type TPE, 1,2-polybutadiene,
So-called thermoplastic elastomers such as trans-polyisoprene can be used, and especially thermoplastic elastomers are
It is excellent in the effect development of antifungal agents, injection moldability, and texture when mounted on the human body. According to the research conducted by the inventors of the present application, an excellent composition was successfully trial-produced by using Kuraray's Hypler as the thermoplastic elastomer.
【0020】上記するように、セラミック粉体は、有機
高分子材料にできるだけ多量に添加することが、その治
療効果の上で好ましいが、上記一般の有機高分子材料で
は、セラミック粉体の添加量に限度がある。多量のセラ
ミック材料を添加するためには、結合媒体の有機高分子
材料の粘度ができるだけ低いことが好ましい。As described above, it is preferable to add the ceramic powder to the organic polymer material as much as possible in terms of its therapeutic effect. However, in the above general organic polymer material, the addition amount of the ceramic powder is large. Is limited. In order to add a large amount of ceramic material, it is preferable that the viscosity of the organic polymer material of the binding medium is as low as possible.
【0021】防カビ剤は、上記する一般的な防カビ剤を
使用できるが、皮膚への刺激などを考慮すると、1のフ
ェノール系化合物と、2の有機銅化合物は好ましくな
い。添加量は、0.5 〜10.0重量部が適当であり、より好
ましくは3〜7重量部がよいが、この添加量が少ないと
水虫発生の抑制効果が小さくなる。逆に多いと成形前の
練り込んだ組成物からの滲み出しが大きくなり、成形
中、押出機や射出成形機のスクリューと練り込んだ組成
物の間に滑りを生じ、成形性に問題が生じる。As the antifungal agent, the above-mentioned general antifungal agents can be used, but in consideration of skin irritation, the phenolic compound 1 and the organocopper compound 2 are not preferable. The addition amount is suitably 0.5 to 10.0 parts by weight, more preferably 3 to 7 parts by weight, but if the addition amount is small, the effect of suppressing athlete's foot is reduced. On the contrary, if the amount is large, the exudation from the kneaded composition before molding becomes large, and slippage occurs between the screw of the extruder or the injection molding machine and the kneaded composition during molding, which causes a problem in moldability. .
【0022】この防カビ剤の添加は、成形時に有機高分
子材料に練り込んだ状態において、防カビ剤が練り込ん
だ組成物の表面に拡散して、高分子材料がゴム状である
と(使用温度が、その高分子材料のガラス転移温度より
高い場合)、防カビ剤が高分子材料中を容易に拡散でき
るため、特に有効であり、成形後の組成物の表面側に防
カビ剤が表れる。この点からも、本発明の場合、一般の
硬質合成樹脂類に比べ、熱可塑性エラストマーを使用す
るのが最適である。When the antifungal agent is added to the organic polymer material at the time of molding, the antifungal agent diffuses to the surface of the composition into which the antifungal agent has been kneaded so that the polymer material is rubber-like ( When the temperature of use is higher than the glass transition temperature of the polymer material), the fungicide is particularly effective because it can easily diffuse in the polymer material. appear. From this point as well, in the case of the present invention, it is optimal to use a thermoplastic elastomer as compared with general hard synthetic resins.
【0023】上記するように、本発明の場合、遠赤外線
の発生源としてのセラミック粉体は、その治療効果の面
からできるだけ多量に添加することが好ましく、このた
め結合媒体の有機高分子材料の粘度が低いことが好まし
い。従って、本発明の成形には、射出成形によらず、ポ
リ塩化ビニル樹脂と可塑剤からなるペーストを先ずセラ
ミック粉体とブレンドし、次にこれを加熱融着する、所
謂ペースト成形法により、本発明の組成物を成形するの
が最適である。勿論、射出成形などの他の成形法を使用
することもできる。なお、防カビ剤は、上記成形時のセ
ラミック粉体と有機高分子材料の練り込みの際に添加す
る。As described above, in the present invention, it is preferable to add as much ceramic powder as a source of far infrared rays as possible from the viewpoint of its therapeutic effect. It is preferable that the viscosity is low. Therefore, in the molding of the present invention, a paste composed of a polyvinyl chloride resin and a plasticizer is first blended with a ceramic powder, and then the mixture is heated and fused by a so-called paste molding method, not by injection molding. Optimally, the composition of the invention is molded. Of course, other molding methods such as injection molding can also be used. The fungicide is added when the ceramic powder and the organic polymer material are kneaded at the time of molding.
【0024】本発明の組成物は、図1,2に示すように
円盤状と角状の組成物1,2に成形されているが、この
形状に限定されるものでなく、種々の形状に成形でき
る。例えば、図3に示すように表面を渦巻き状の組成物
3としたり、図4のように内部に磁石4をインサートし
た組成物5に成形できる。The composition of the present invention is molded into disc-shaped and angular-shaped compositions 1 and 2 as shown in FIGS. 1 and 2, but is not limited to this shape, and various shapes are possible. Can be molded. For example, as shown in FIG. 3, the composition 3 may have a spiral surface, or as shown in FIG. 4, a composition 5 having a magnet 4 inserted therein may be molded.
【0025】この組成物5の構成は、上側片6と下側片
7の内部に磁石4をインサートして一体化構成としてあ
る。磁石4は、表面磁束密度が200〜20000ガウ
ス程のものが好ましく、より好ましくは1000〜10
000ガウスが最適である。また、上側片6と下側片7
は、上記する組成物1〜3と同じ組成で構成され、上側
片6の表面に右方向或いは左方向の渦巻き8が形成され
ている。9は粘着性シートを示し、患部への装着に便利
な構成としてある。The composition 5 has a structure in which the magnet 4 is inserted inside the upper piece 6 and the lower piece 7 to form an integrated structure. The magnet 4 preferably has a surface magnetic flux density of about 200 to 20000 gauss, more preferably 1000 to 10
000 gauss is optimal. Also, the upper piece 6 and the lower piece 7
Has the same composition as the above-mentioned compositions 1 to 3, and the spiral 8 in the right direction or the left direction is formed on the surface of the upper piece 6. Reference numeral 9 denotes an adhesive sheet, which has a structure that is convenient for attachment to the affected area.
【0026】これを具体的に説明すると、ポリエチレン
・ペレット60重量部、粒度範囲10〜100μのチタ
ン酸アルミニウム粒体38重量部、ナフテン酸亜鉛2重
量部をタンブラーで混合した後、押出機で押し出してペ
レット化する。その後、表面磁気密度7500ガウスの
磁石(直径1.5 cm,長さ5mmの円形状のもの)をイ
ンサートして射出成形し、直径5cm,厚さ1cmの円
盤状の治療器体を構成する組成物5を得た。More specifically, 60 parts by weight of polyethylene pellets, 38 parts by weight of aluminum titanate particles having a particle size range of 10 to 100 μ, and 2 parts by weight of zinc naphthenate were mixed by a tumbler and then extruded by an extruder. Pelletize. Thereafter, a magnet having a surface magnetic density of 7500 gauss (circular shape having a diameter of 1.5 cm and a length of 5 mm) was inserted and injection-molded to form a disk-shaped therapeutic device body having a diameter of 5 cm and a thickness of 1 cm. Got
【0027】また、この組成物5の裏面、具体的には下
側片7の裏面にアルミニウム箔を貼ることにより、遠赤
外線を一方向、つまり患部の方向に集約させ、その治療
効果を向上させることができる。さらに、下側片7を省
いて、上側片6のみで一体成形するなどの変更は設計事
項である。Further, by attaching an aluminum foil to the back surface of the composition 5, more specifically, the back surface of the lower piece 7, the far infrared rays are concentrated in one direction, that is, the direction of the affected area, and the therapeutic effect thereof is improved. be able to. Further, a modification such as omitting the lower piece 7 and integrally molding only the upper piece 6 is a design matter.
【0028】さらに、本願発明者らが行った実施結果に
ついて説明し、本発明の治療効果が有効であることを説
明する。実施例1は、次の条件により組成物を調製し
た。ポリエチレン・ペレット60重量部、粒度10〜1
00μのチタン酸アルミニウム粉体38重量部、ナフテ
ン酸亜鉛2重量部をタンブラーで混合後、押出機で押し
出してペレット化し、このペレットを射出成形法によ
り、20×20×2mmの角状の組成物の試作品1を成
形した。Furthermore, the results of the implementation carried out by the inventors of the present application will be described to explain that the therapeutic effect of the present invention is effective. In Example 1, a composition was prepared under the following conditions. Polyethylene pellet 60 parts by weight, grain size 10-1
38 parts by weight of 00μ aluminum titanate powder and 2 parts by weight of zinc naphthenate were mixed in a tumbler, and then extruded into pellets by an extruder, and the pellets were formed into a 20 × 20 × 2 mm square composition by injection molding. A prototype 1 of was molded.
【0029】この試作品1を常日頃水虫に悩まされ、か
つ足の疲労を訴えている金型工Aの靴下の中に入れ、所
謂土踏まずの部分に当てがった。この状態で重い金型を
選ぶ作業を続けた結果、約3週間後に足の疲労を感じ、
また約1カ月半後に水虫の発生が認められた。この試作
品1を使用しないで金型工Aが同様な作業をすると、約
1週間で足の疲労を感じ、また約3週間で水虫の発生が
認められた。This prototype 1 was put into the socks of the mold maker A who suffered from athlete's foot and complained of foot fatigue on a regular basis, and applied to the so-called arch part. As a result of continuing the work of choosing a heavy mold in this state, I felt fatigue in my legs after about 3 weeks,
In addition, the development of athlete's foot was observed after about one and a half months. When the die work A carried out the same work without using this prototype 1, the foot fatigue was felt in about 1 week, and the occurrence of athlete's foot was observed in about 3 weeks.
【0030】実施例2は、株式会社クラレ製のポリスチ
レン−ビニルポリイソプレン・ブロックポリマー、ハイ
ブラ−VS−1のペレット60重量部、粒度10〜10
0μチタン酸アルミニウム粉体38重量部、ナフテン酸
亜鉛2重量部を実施例1と同様な成形法で、かつ同形状
の試作品2を成形し、実施例1と同様な症状のある金型
工Bの靴下に入れ、土踏まずの部分に当てがい、作業を
続けた。In Example 2, polystyrene-vinyl polyisoprene block polymer manufactured by Kuraray Co., Ltd., 60 parts by weight of pellets of Hybra-VS-1 and particle size of 10 to 10 were used.
38 μ parts of 0 μ aluminum titanate powder and 2 parts by weight of zinc naphthenate were molded by the same molding method as in Example 1 and a prototype 2 having the same shape was molded. I put it in the sock of B, applied it to the part of the arch, and continued the work.
【0031】その結果、約3週間後に足の疲労を感じ、
約3カ月後に水虫の発生が認められた。上記実施例1に
示したポリエチレン(硬質ポリマー)に比し、試作品2
の軟質セグメントを有するハイブラーを用いた場合、防
カビ剤がより有効に作用し、水虫の抑制に効果があるこ
とが確認できた。As a result, after about 3 weeks, I felt fatigue in my legs,
Occurrence of athlete's foot was observed after about 3 months. Compared to the polyethylene (hard polymer) shown in Example 1 above, prototype 2
It was confirmed that, when the high blur having the soft segment of No. 3 was used, the antifungal agent acted more effectively and had the effect of suppressing athlete's foot.
【0032】実施例3は、上記ハイブラーV−1のペレ
ット60重量部、粒度10〜100μのチタン酸アルミ
ニウム粉体38重量部、ナフテン酸亜鉛2重量部を用い
て、同様な成形法で、かつ同様な角状に成形する際、表
面磁束密度2000ガウスの小型磁石を中心部にインサ
ートした試作品3を成形した。In Example 3, 60 parts by weight of the above-mentioned Hybler V-1 pellets, 38 parts by weight of aluminum titanate powder having a particle size of 10 to 100 μ, and 2 parts by weight of zinc naphthenate were used in the same molding method, and At the time of forming into a similar angular shape, a prototype 3 was formed in which a small magnet having a surface magnetic flux density of 2000 gauss was inserted in the center.
【0033】同様な症状の金型工Cに使用した。その結
果、約3カ月後、足の疲労と水虫の発生が認められた。
この実施例3は、実施例2に比較して、疲労抑制に磁気
の併用効果が顕著であることが確認できた。It was used for a mold C having the same symptoms. As a result, after about 3 months, foot fatigue and the development of athlete's foot were observed.
It was confirmed that in Example 3, the combined effect of magnetism was remarkable in suppressing fatigue as compared with Example 2.
【0034】実施例4は、上記実施例3と同様な配合に
より、同形の角状に成形する際、表面磁束2000ガウ
スの小形磁石を中心部にインサートし、その表面を右渦
巻き状の模様を施した試作品4を成形した。そして、こ
の模様が土踏まずに配するようにして同様な症状の金型
工Dに使用した結果、約4カ月後足の疲労を感じ、約3
カ月後水虫の発生が認められた。実施例3に比べ、この
実施例4の右渦巻き状の模様が、疲労の抑制に作用する
ことが確認できた。In Example 4, the same composition as in Example 3 above was used to form a rectangular magnet of the same shape. A small magnet having a surface magnetic flux of 2000 gauss was inserted in the center of the surface, and the surface was formed into a right spiral pattern. The provided prototype 4 was molded. Then, as a result of using this pattern on the arch of the metal mold D, which had the same symptoms, as a result of using it for about 4 months, I felt fatigue in my hind legs and about 3
After a month, the development of athlete's foot was observed. It was confirmed that the right spiral pattern of Example 4 acts to suppress fatigue as compared with Example 3.
【0035】実施例5は、上記実施例4の片面にアルミ
ニウム箔を貼った試作品5を同様な症状の金型工Eに使
用した場合、約4カ月後に足の疲労を感じ、約6カ月後
に水虫の発生が認められた。これは実施例4に比べ、ア
ルミニウム箔による遠赤外線の反射効果が有効に作用す
ることが認められた。In Example 5, when the prototype 5 in which aluminum foil was pasted on one surface of Example 4 was used in the mold E having the same symptoms, fatigue of the foot was felt after about 4 months and about 6 months. Later, the development of athlete's foot was observed. It was confirmed that the effect of reflecting the far infrared rays by the aluminum foil worked more effectively than in Example 4.
【0036】実施例6は、軟質ポリ塩化ビニル(塩ビ重
合度1300,可塑剤量80PHR)60重量部、粒度
10〜100μのコージライト粒体38重量部、トリエ
チル−n−オクチル錫2重量部をタンブラーで混合後、
同様な成形法により、同形状の試作品6を成形した。同
じ症状の金型工Fに使用した結果、約3週間後に足の疲
労を感じ、約3カ月後に水虫の発生が認められ、実施例
2とほぼ等しい結果となった。In Example 6, 60 parts by weight of soft polyvinyl chloride (vinyl chloride polymerization degree: 1300, plasticizer amount: 80 PHR), 38 parts by weight of cordierite particles having a particle size of 10 to 100 μ, and 2 parts by weight of triethyl-n-octyltin were used. After mixing with a tumbler,
A prototype 6 having the same shape was molded by the same molding method. As a result of using it in the mold maker F having the same symptoms, fatigue of the foot was felt after about 3 weeks and the occurrence of athlete's foot was observed after about 3 months, and the results were almost the same as in Example 2.
【0037】実施例7は、上記実施例6の防カビ剤をフ
ェニルマーキュリックアセテート2重量部とした試作品
7を同じ症状の金型工Gに使用した場合、約3週間後に
足の疲労を感じ、約3カ月後に水虫の発生が認められ、
実施例2とほぼ等しい結果となった。In Example 7, when the trial product 7 containing 2 parts by weight of phenylmercuric acetate as the antifungal agent of Example 6 was used in the mold maker G having the same symptoms, foot fatigue was observed after about 3 weeks. Feeling, the development of athlete's foot was observed after about 3 months,
The result is almost equal to that of the second embodiment.
【0038】実施例8は、同様に防カビ剤としてエチル
ベンゾイルインドール2重量部とした試作品8を同じ症
状の金型工Hに使用した。その結果、実施例とほぼ等し
く、約3週間後に足の疲労を感じ、約3カ月後に水虫の
発生が確認された。In Example 8, similarly, a prototype 8 containing 2 parts by weight of ethylbenzoylindole as an antifungal agent was used in the mold H having the same symptoms. As a result, it was almost the same as in the Example, and the fatigue of the foot was felt after about 3 weeks, and the occurrence of athlete's foot was confirmed after about 3 months.
【0039】実施例9は、乳化重合法によって製造した
ポリ塩化ビニル樹脂粉体5重量部、可塑剤5重量部及び
粒度10〜100μのコージライト粉体88重量部、エ
チルベンゾイルインドール2重量部を同様な成形法で、
同様な形状の試作品9に成形した。In Example 9, 5 parts by weight of a polyvinyl chloride resin powder produced by an emulsion polymerization method, 5 parts by weight of a plasticizer, 88 parts by weight of cordierite powder having a particle size of 10 to 100 μ, and 2 parts by weight of ethylbenzoylindole were used. With the same molding method,
A prototype 9 having a similar shape was formed.
【0040】この試作品9を同じ症状の金型工Iに使用
した結果、約3カ月後に足の疲労と約5カ月後に水虫の
発生が認められた。この塩ビ・ペースト法により、コー
ジライトの比率を高めることができ、その結果、実施例
2に比べ、その疲労防止効果が高められたものと考え
る。As a result of using this prototype 9 in the mold I having the same symptoms, fatigue of the foot was observed after about 3 months and the occurrence of athlete's foot after about 5 months. This vinyl chloride paste method can increase the cordierite ratio, and as a result, it is considered that the fatigue preventing effect is enhanced as compared with the second embodiment.
【0041】次に、これら実施例1〜9の効果を確認す
るため、本願発明者らが行った比較例について説明す
る。比較例1は、ポリエチレン樹脂ペレット98重量部
に、ナフテン酸亜鉛2重量部をタンブラーで混合後、押
出機でペレット化し、射出成形法により20×20×2
mmの角状の比較品1を成形し、上記金型工Aの土踏ま
ずに当てがって、金型作業を続けた。Next, a comparative example conducted by the inventors of the present application in order to confirm the effects of Examples 1 to 9 will be described. In Comparative Example 1, 98 parts by weight of polyethylene resin pellets and 2 parts by weight of zinc naphthenate were mixed in a tumbler, pelletized by an extruder, and then 20 × 20 × 2 by injection molding.
A square mm comparative product 1 having a size of mm was molded, applied to the arch of the above-mentioned mold builder A, and the mold work was continued.
【0042】その結果、約1週間後に足の疲労を感じ、
約3週間後に水虫の発生が認められた。この結果は、実
施例1に比べ、疲労防止、水虫発生の抑制は、共に劣っ
ており、セラミック粉の併用がないと、2重量部のナフ
テン酸亜鉛は、水虫防止に対し、その抑制効果が殆どな
いことが確認できる。As a result, after about one week, I felt fatigue in my legs,
Occurrence of athlete's foot was observed after about 3 weeks. This result is inferior to Example 1 in preventing fatigue and suppressing the occurrence of athlete's foot, and 2 parts by weight of zinc naphthenate has an inhibitory effect on athlete's foot prevention without the combined use of ceramic powder. It can be confirmed that there is almost no.
【0043】比較例2として、ハイブラー−VS−1の
ペレット60重量部、粒度10〜100μのチタン酸ア
ルミニウム粉体40重量部を同様に、かつ同形状に成形
した比較品2を上記金型工Bに使用した。結果は、約3
週間後に足の疲労を感じ、また約1カ月後に水虫の発生
が認められた。水虫防止には、セラミック粉のみの添加
でも一応の効果は認められるが、あまり顕著な効果でな
いことが確認できた。As Comparative Example 2, 60 parts by weight of the pellets of Hybler-VS-1 and 40 parts by weight of aluminum titanate powder having a grain size of 10 to 100 μ were molded into the same shape and in the same shape as the above-mentioned mold working. Used for B. The result is about 3
Feet fatigue was felt after a week, and the development of athlete's foot was observed after about 1 month. For the prevention of athlete's foot, it was confirmed that the addition of only ceramic powder had some effect, but it was not so remarkable.
【0044】上記各実施例による試作品1〜9と比較例
による比較品1,2との結果を表すと表1に示す通りと
なり、本発明に係る治療器体の組成物は、肩,手,足な
どの凝りや腰痛から足腰の疲労感の回復、さらに水虫の
抑制などの治癒促進に有効に作用することが確認でき
た。The results of the prototypes 1 to 9 according to each of the above-described examples and the comparative products 1 and 2 according to the comparative examples are shown in Table 1. The composition of the therapeutic device according to the present invention is used for the shoulders and hands. , It was confirmed that it is effective for recovery of tiredness of legs and feet from stiffness of the legs and back pain, and promotion of healing such as suppression of athlete's foot.
【0045】[0045]
【表1】 [Table 1]
【0046】[0046]
【発明の効果】以上説明したように、本発明によれば、
組成物を構成する磁力線と遠赤外線との相乗効果によ
り、患部の治療或いは痛みなどの軽減が図れ、肩,手,
足などの凝りや腰痛から足腰の疲労感の回復に有効に作
用するものである。As described above, according to the present invention,
Due to the synergistic effect of the magnetic lines of force and far-infrared rays that make up the composition, treatment of the affected area or reduction of pain can be achieved, and the shoulders, hands,
It is effective in recovering the fatigue of the legs and waist from stiffness in the legs and back pain.
【0047】また、防カビ剤のはたらき、水虫の発生及
び抑制を図ることができる。Further, the function of the antifungal agent can be promoted and the occurrence and control of athlete's foot can be achieved.
【図1】本発明の第1例を示す斜視図。FIG. 1 is a perspective view showing a first example of the present invention.
【図2】本発明の第2例を示す斜視図。FIG. 2 is a perspective view showing a second example of the present invention.
【図3】本発明の第3例を示す斜視図。FIG. 3 is a perspective view showing a third example of the present invention.
【図4】本発明の第4例を示す斜視図FIG. 4 is a perspective view showing a fourth example of the present invention.
1,2,3 組成物 1,2,3 composition
Claims (2)
なるセラミック粉体10〜90重量部と、防カビ剤0.5
〜10.0重量部と、残部を結合媒体となる有機高分子材料
とすることを特徴とする治療器体の組成物。1. A ceramic powder which is a source of far infrared rays having a diameter of 2 to 500 μ, and 10 to 90 parts by weight, and a fungicide 0.5.
A composition for a therapeutic device, characterized by comprising ˜10.0 parts by weight and the balance of an organic polymer material as a binding medium.
ガウスの磁石をインサートして一体成形したことを特徴
とする請求項1記載の治療器体の組成物。2. A surface magnetic flux density of 200 to 20000 inside
The composition of the therapeutic device body according to claim 1, wherein a Gaussian magnet is inserted and integrally molded.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5187562A JPH0788201A (en) | 1993-06-30 | 1993-06-30 | Therapeutic device composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5187562A JPH0788201A (en) | 1993-06-30 | 1993-06-30 | Therapeutic device composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0788201A true JPH0788201A (en) | 1995-04-04 |
Family
ID=16208259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5187562A Pending JPH0788201A (en) | 1993-06-30 | 1993-06-30 | Therapeutic device composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0788201A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171485B1 (en) * | 1995-04-25 | 2001-01-09 | Kueke Fritz | Process for producing a chlorine dioxide-containing disinfectant solution for water treatment |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0219250A (en) * | 1988-06-29 | 1990-01-23 | Yasuro Kuratomi | Glass ware with far ultrared ray radiation material |
-
1993
- 1993-06-30 JP JP5187562A patent/JPH0788201A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0219250A (en) * | 1988-06-29 | 1990-01-23 | Yasuro Kuratomi | Glass ware with far ultrared ray radiation material |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171485B1 (en) * | 1995-04-25 | 2001-01-09 | Kueke Fritz | Process for producing a chlorine dioxide-containing disinfectant solution for water treatment |
| US6428696B2 (en) * | 1995-04-25 | 2002-08-06 | Kueke Fritz | Process for preparing a chlorine-dioxide-containing disinfectant solution for water treatment |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101834116B1 (en) | An antimicrobial resin and the manufacturing method thereof | |
| CN104802358A (en) | Latex product production process | |
| JPH0788201A (en) | Therapeutic device composition | |
| CN222473590U (en) | Moistureproof and mildewproof 3D mesh cloth for carpet | |
| GR3022720T3 (en) | Pyrethroid containing shaped articles made of thermoplastic workable elastomeric copolyesters, method for their preparation and use for the control of pests | |
| TW201236601A (en) | Toothbrush having far infrared and anion and manufacturing method thereof | |
| CN205107119U (en) | Skin makeup health care bolster | |
| CN207370443U (en) | A kind of elastic pillow with antibiotic plastic particle | |
| JPH0471419B2 (en) | ||
| EP1400576A1 (en) | Adhesive | |
| CN211933585U (en) | Sterilization wire coil pad | |
| CN222466195U (en) | A kind of microfiber imitation shoe leather | |
| CN204978811U (en) | A steering wheel cover that is used for outer snare body of steering wheel and contains outer snare body | |
| CN2868330Y (en) | Magnet therapy body-building shoe pad | |
| US20140234394A1 (en) | Benefical contact surfaces for functional objects | |
| CN210887915U (en) | Carbon crystal floor | |
| CN201641134U (en) | Chair | |
| TW201236613A (en) | Chopstick having far infrared and anion and manufacturing method thereof | |
| JP2525722Y2 (en) | Health mat | |
| JPH0623524Y2 (en) | Handbag | |
| JP2005254788A (en) | Tourmaline body in which tourmaline fills internal hollow of sponge | |
| JP3072239U (en) | Rice scoop | |
| JP2004010547A (en) | Ore composition, sheet material containing the same, and sheet-shaped member using the same | |
| CN200959878Y (en) | Anti-skid structure on the surface of the insole | |
| JPH0329291Y2 (en) |